Gonadorelin
Published · Researched 2026-09-21
Category: Libido, Tanning, Sleep & Niche · Research date: 2026-09-20 · Slug: gonadorelin
Overview
Gonadorelin is synthetic GnRH (gonadotropin-releasing hormone, also called LHRH) — the exact native hypothalamic decapeptide sequence, not an analogue. Endogenously it is released in pulses to drive pituitary LH/FSH secretion; exogenously, its claim to fame in grey-market use is pulsatile HPG-axis stimulation for TRT-adjacent and post-cycle "restart" protocols. It sells as 2 mg lyophilized vials (standard) from US and EU research vendors. The critical pharmacology nuance — one the community gets half-right — is that continuous GnRH exposure suppresses the axis (the basis for triptorelin/leuprolide therapy), while only pulsatile exposure stimulates it; the native peptide's half-life is measured in minutes.
Social standing
Instagram: The most visible layer — videos in June/July 2026 targeted TRT users and explained pituitary/testicular signaling; comments sought protocol details and lab interpretation. Much of this content is clinic lead generation, not independent owner reporting — treat accordingly.
Threads: No strong direct owner result; mostly generic peptide posts surfaced. No experience-seeking thread comparable to other items was found.
Facebook: No verified item-level discussion in the surveyed groups.
ExcelMale / TRT forums (context): The broader TRT/fertility forum world discusses GnRH-axis peptides (gonadorelin, triptorelin, HCG) extensively for fertility preservation and restarts — but item-specific gonadorelin owner threads with verifiable detail were not isolated in this pass.
Recurring praise: "works upstream" framing; positioned as the more physiological alternative to HCG for axis support (community framing, not established medicine).
Recurring complaints: the pulsatile-vs-continuous nuance is widely misunderstood; native GnRH's minutes-scale half-life makes practical use questionable (recurring skepticism); much visible content is clinic marketing.
Social validation
Tier: Tier 3 — no verified organic owner discussion isolated on any surveyed platform; visible content is dominated by clinic/influencer education and vendor listings.
Named sources and what each proves:
- Instagram TRT-targeted explainers (June/July 2026) — prove commercial/clinic interest in positioning gonadorelin to TRT users; lead-generation character limits their evidentiary value.
- Vendor listings (CertaPeptides, Luxe Peptides, SwissChems, Finest Gears) — prove the 2 mg vial product is actively sold in US/EU markets.
- Absence of Threads/Facebook owner threads — itself a finding for an item with this much clinic-side promotion.
Key specs table
| Spec | Detail |
|---|---|
| Identity | Gonadorelin (GnRH, LHRH), synthetic native-sequence decapeptide |
| Sequence | pGlu-His-Trp-Ser-Tyr-Gly-Leu-Arg-Pro-Gly-NH2 (as catalog-listed) |
| Formula / MW | C55H75N17O13 · 1182.29 g/mol · CAS 33515-09-2 (as catalog-listed; primary-source verification not performed) |
| Target | GnRH receptor on anterior-pituitary gonadotrophs → LH/FSH release (pulsatile stimulation; continuous exposure desensitizes) |
| Vial sizes (grey market) | 2 mg lyophilized per vial (standard) |
| Half-life | Listed by a vendor as 2–10 minutes (native GnRH); UNVERIFIED against a primary source in this pass, though consistent with the known minutes-scale endogenous half-life |
| Community-reported research use | TRT-adjacent and post-cycle protocol discussion; specifics are clinic-driven and highly variable. Reported behavior only — not instructions. |
| Storage | Lyophilized: −20 °C long-term (vendors also state RT stable ~90 days); reconstituted: 2–8 °C, short use window; avoid freeze–thaw |
Pricing
All prices observed 2026-09-20 from research-peptide vendor listings (grey market, research-use-only), 2 mg vials unless noted.
| Vendor | Price (2 mg vial) | Notes |
|---|---|---|
| CertaPeptides | €16.99 | cheapest observed; EU; volume tiers to 15% off |
| Finest Gears (Ultima) | $24.23 (list $40.32) | out of stock |
| SwissChems | $24.95 | 706 in stock per listing |
| Luxe Peptides | $40.00 | BOGO promo observed |
| Novapeptide (vendor copy) | "$150–$300 per vial" | outlier claim — contradicts all live listings; treated as vendor hype, not market data |
| China EXW price list | $25 per 10-vial box (2 mg/vial) | wholesale supplier data, not street pricing |
- Street range: roughly $24–$40 per 2 mg vial (US), ~€17 (EU) — inexpensive as peptides go.
- Facebook Marketplace: not searched in this pass — used-value range UNVERIFIED.
What's included / what's needed
Vial listings ship the lyophilized 2 mg vial only (some vendors add a per-lot COA). Needed separately: bacteriostatic water, insulin syringes. No kit-style bundles observed as standard.
Support reality
No manufacturer warranty on research vials; vendor guarantees are vendor policies only. The item's positioning toward TRT users by clinics creates a two-tier market: clinic-supervised (real medical oversight, not evaluated here) vs. grey-market vials (no oversight, COA-only quality). No independent certification body exists for the latter.
Community verdict
Gonadorelin is better marketed than it is discussed: clinics push it to TRT users, vendors stock it cheaply, but the organic owner conversation is nearly invisible. The pharmacology nuance that matters most — pulsatile stimulation vs. continuous suppression — is exactly what casual discussion gets wrong, which makes the thin evidence base a genuine safety-relevant gap rather than just a research inconvenience.
Regulatory & safety status
- Factrel (gonadorelin) had an FDA diagnostic indication for evaluating pituitary gonadotroph function; current marketing/approval status UNVERIFIED in this pass — assume no active US human product without verification.
- Grey-market vials and off-label TRT/"restart" use are not approved uses anywhere identified.
- Native GnRH's minutes-scale half-life is the central practical problem: achieving true pulsatile delivery outside a pump is not what vial self-use typically accomplishes — and continuous exposure suppresses the axis (the triptorelin mechanism). This inversion risk is the key safety-relevant pharmacology point.
- Community adverse-event consensus: UNVERIFIED — no reliable reporting base was observed.
Image views
4 of 8 views obtained (vendor product images, JPEG; converted from PNG/WebP originals). Top-angle, scale, box-accessories, and real-owner-in-use views were unavailable.
- hero:
img/gonadorelin-hero.jpg(Shopify-listed Gonadorelin 2 mg 3 mL vial) - side:
img/gonadorelin-side.jpg(Peptide.cn Gonadorelin 2 mg) - rear:
img/gonadorelin-rear.jpg(Pure Health Peptides Gonadorelin) - detail:
img/gonadorelin-detail.jpg(AdaptoG Research Gonadorelin 10 mg) - top-angle: unavailable
- scale: unavailable — no vendor image with a size reference found
- box-accessories: unavailable
- real-owner-in-use: unavailable — no verifiable real-owner product photos found
Not medical advice. This is research documentation only. Gonadorelin research vials are not approved for human use, and misunderstanding its pulsatile pharmacology can produce the opposite of the intended hormonal effect. Consult a licensed healthcare provider.
Named sources
- Instagram TRT-targeted explainers (June/July 2026) — prove commercial/clinic interest in positioning gonadorelin to TRT users (July 2026)
- Vendor listings (CertaPeptides, Luxe Peptides, SwissChems, Finest Gears) — prove the 2 mg vial product is actively sold in US/EU markets.
- Absence of Threads/Facebook owner threads — itself a finding for an item with this much clinic-side promotion.
- TRT forum — *ExcelMale / TRT forums (context):** The broader TRT/fertility forum world discusses GnRH-axis peptides (gonadorelin, triptorelin, HCG) extensively for fertility preservation and restarts — but item-specific gonadorelin owner threads with verifiable detail…
- TRT/fertility forum — *ExcelMale / TRT forums (context):** The broader TRT/fertility forum world discusses GnRH-axis peptides (gonadorelin, triptorelin, HCG) extensively for fertility preservation and restarts — but item-specific gonadorelin owner threads with verifiable detail…
Source URLs were not recorded for these references.